154 related articles for article (PubMed ID: 24490472)
1. [Prolonged-release drug formulations for parenteral administration. Part l. Suspensions and oily solutions for injection].
Płaczek M; Jacyna J; Sznitowska M
Pol Merkur Lekarski; 2013 Dec; 35(210):391-6. PubMed ID: 24490472
[TBL] [Abstract][Full Text] [Related]
2. [Prolonged-release drug formulations for parenteral administration. Part II. Microspheres and implants for injection].
Płaczek M; Jacyna J; Sznitowska M
Pol Merkur Lekarski; 2014 Jan; 36(211):54-8. PubMed ID: 24645581
[TBL] [Abstract][Full Text] [Related]
3. Role of in vitro release models in formulation development and quality control of parenteral depots.
Larsen C; Larsen SW; Jensen H; Yaghmur A; Ostergaard J
Expert Opin Drug Deliv; 2009 Dec; 6(12):1283-95. PubMed ID: 19941410
[TBL] [Abstract][Full Text] [Related]
4. Sustained release veterinary parenteral products.
Medlicott NJ; Waldron NA; Foster TP
Adv Drug Deliv Rev; 2004 Jun; 56(10):1345-65. PubMed ID: 15191786
[TBL] [Abstract][Full Text] [Related]
5. [Technological and pharmacotherapeutic properties of selected drugs with modified release of diclofenac sodium].
Kołodziejczyk MK; Kołodziejska J; Zgoda MM
Polim Med; 2012; 42(2):121-32. PubMed ID: 23016443
[TBL] [Abstract][Full Text] [Related]
6. Characteristics of a novel phospholipid-based depot injectable technology for poorly water-soluble drugs.
Tiemessen H; van Hoogevest P; Leigh ML
Eur J Pharm Biopharm; 2004 Nov; 58(3):587-93. PubMed ID: 15451533
[TBL] [Abstract][Full Text] [Related]
7. [The use of natural and synthetic hydrophilic polymers in the formulation of metformin hydrochloride tablets with different profile release].
Kołodziejczyk MK; Kołodziejska J; Zgoda MM
Polim Med; 2012; 42(3-4):167-84. PubMed ID: 23457958
[TBL] [Abstract][Full Text] [Related]
8. In-vitro dissolution methods for controlled release parenterals and their applicability to drug-eluting stent testing.
Seidlitz A; Weitschies W
J Pharm Pharmacol; 2012 Jul; 64(7):969-85. PubMed ID: 22686343
[TBL] [Abstract][Full Text] [Related]
9. Novel oral suspensions: a review.
Kathpalia H; Phadke C
Curr Drug Deliv; 2014; 11(3):338-58. PubMed ID: 24410269
[TBL] [Abstract][Full Text] [Related]
10. Impact of Formulation Parameters on In Vitro Release from Long-Acting Injectable Suspensions.
Bao Q; Zou Y; Wang Y; Choi S; Burgess DJ
AAPS J; 2021 Mar; 23(2):42. PubMed ID: 33709196
[TBL] [Abstract][Full Text] [Related]
11. In vitro assessment of lidocaine release from aqueous and oil solutions and from preformed and in situ formed aqueous and oil suspensions. Parenteral depots for intra-articular administration.
Pedersen BT; Larsen SW; Østergaard J; Larsen C
Drug Deliv; 2008 Jan; 15(1):23-30. PubMed ID: 18197520
[TBL] [Abstract][Full Text] [Related]
12. Sustained-release injectables formed in situ and their potential use for veterinary products.
Matschke C; Isele U; van Hoogevest P; Fahr A
J Control Release; 2002 Dec; 85(1-3):1-15. PubMed ID: 12480306
[TBL] [Abstract][Full Text] [Related]
13. Accelerated in-vitro release testing methods for extended-release parenteral dosage forms.
Shen J; Burgess DJ
J Pharm Pharmacol; 2012 Jul; 64(7):986-96. PubMed ID: 22686344
[TBL] [Abstract][Full Text] [Related]
14. Development of shellac-coated sustained release pellet formulations.
Farag Y; Leopold CS
Eur J Pharm Sci; 2011 Mar; 42(4):400-5. PubMed ID: 21251975
[TBL] [Abstract][Full Text] [Related]
15. [Lipid vehicles for the parenteral administration of drugs (1): emulsions].
Bermejo Vicedo T; Hidalgo Correas FJ; Carrasco JM
Nutr Hosp; 1996; 11(1):7-16. PubMed ID: 8704021
[TBL] [Abstract][Full Text] [Related]
16. In vitro release from oil injectables for intra-articular administration: Importance of interfacial area, diffusivity and partitioning.
Thing M; Larsen C; Østergaard J; Jensen H; Larsen SW
Eur J Pharm Sci; 2012 Feb; 45(3):351-7. PubMed ID: 22178293
[TBL] [Abstract][Full Text] [Related]
17. The role of solid nanoparticle technology in the parenteral delivery of poorly water-soluble drugs.
Kipp JE
Int J Pharm; 2004 Oct; 284(1-2):109-22. PubMed ID: 15454302
[TBL] [Abstract][Full Text] [Related]
18. Preliminary evaluation of the in vitro release and in vivo absorption in rabbits of the modified-release dosage forms.
Petrovic AA; Petricevic SM; Ristic SM; Ibric SR; Simic SS; Djuric ZR; Popovic RB
Drug Dev Ind Pharm; 2013 Jun; 39(6):889-900. PubMed ID: 22905673
[TBL] [Abstract][Full Text] [Related]
19. In vitro evaluation of the dissolution rate of crystalline suspensions destined to intramuscular administration.
Cadorniga R; Burgos ML; Negro S; Nernanez MT; Pastoriza P; Molina IT
Eur J Drug Metab Pharmacokinet; 1991; Spec No 3():379-84. PubMed ID: 1820911
[TBL] [Abstract][Full Text] [Related]
20. New aspects in sustained drug release formulations.
Bikiaris D; Koutris E; Karavas E
Recent Pat Drug Deliv Formul; 2007; 1(3):201-13. PubMed ID: 19075887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
